Back to UBS Group AG UBS Group AG

VCNXVCNX
4 quarters

Position history for UBS Group AGUBS Group AG's holdings in Vaccinex, Inc.

UBS Group AG previously held 0 shares of VCNX (Vaccinex, Inc.), worth $0 as of 2024-Q4.

Final Value

$0

Final Shares

0

Total Value Change

-$748

Total Shares Change

-101

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2024-Q4
Latest
Exited
0
-100.0%
$00.0%$1.10
0
2024-Q3
New
3,402
-
$11,5670.0%$3.36
27
2024-Q2
Exited
0
-100.0%
$00.0%$6.49
0
2024-Q1
New
101
-
$7480.0%$7.41
17

Other major holders of VCNX: Point72 Asset Management, L.P., MORGAN STANLEY, GROUP ONE TRADING LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used